Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Tuberous sclerosis complex gene identified

Aug. 14, 1997

YM-872 shows potential for stroke in animal models

Aug. 13, 1997

Antiischemic activity of calmodulin antagonist reported

Aug. 13, 1997

NR2B-selective NMDA antagonist for occlusive stroke

Aug. 13, 1997

Bradykinin antagonist shows potential in stroke and ischemic disorders

Aug. 13, 1997

YM90K efficacy shown in rat model of cerebral ischemia

Aug. 13, 1997

Endothelin antagonists for cerebral ischemia

Aug. 13, 1997

P&U antioxidant shows cerebroprotective activity in rats

Aug. 13, 1997

Elan licenses Morphelan to Targon Corporation

Aug. 13, 1997

Imminent launch of Novartis' Alzheimer's disease therapy

Aug. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...